Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Feb;31(2):267–273. doi: 10.1128/aac.31.2.267

In vitro activity of CGP 31608, a new penem.

R Wise, J M Andrews, L J Piddock
PMCID: PMC174704  PMID: 3105451

Abstract

The in vitro activity of CGP 31608, a semisynthetic penem derivative, was compared with that of Sch 34343, imipenem, cefoxitin, cefuroxime, and ceftazidime and other beta-lactams, when appropriate, against 628 recent isolates and other beta-lactam-resistant strains. The MICs of CGP 31608 against 90% of the members of the family Enterobacteriaceae, Pseudomonas aeruginosa, Haemophilus influenzae, Neisseria spp., Bacteroides spp., Clostridium spp., staphylococci, and Streptococcus pneumoniae were between 0.25 and 8 micrograms/ml. The susceptibility of beta-lactamase-producing strains and known porin mutants of the Enterobacteriaceae suggests that CGP 31608 is resistant to many important beta-lactamases (including the mutationally derepressed chromosomal enzymes) and is not excluded from the bacterial cell in strains expressing these known porin mutations. Generally, CGP 31608 was less active than imipenem, Sch 34343, and the cephalosporins, except against Pseudomonas aeruginosa. The activity of CGP 31608 against Staphylococcus aureus (including methicillin-resistant strains) was greater than that of the cephalosporins. The major target site in Escherichia coli K-12 for CGP 31608 was penicillin-binding protein 2. The serum protein binding of 5 micrograms of CGP 31608 per ml was 14%, and serum had little effect on activity.

Full text

PDF
267

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Curtis N. A., Brown C., Boxall M., Boulton M. G. Inhibition of Escherichia coli K-12 by beta-lactam antibiotics with poor antibacterial activity: interaction of permeability and intrinsic activity against penicillin-binding proteins. Antimicrob Agents Chemother. 1979 Mar;15(3):332–336. doi: 10.1128/aac.15.3.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Curtis N. A., Eisenstadt R. L., Turner K. A., White A. J. Porin-mediated cephalosporin resistance in Escherichia coli K-12. J Antimicrob Chemother. 1985 May;15(5):642–644. doi: 10.1093/jac/15.5.642. [DOI] [PubMed] [Google Scholar]
  3. Ganguly A. K., Afonso A., Girijavallabhan V. M., McCombie S. Synthesis and preliminary in-vitro profile of Sch 34343--a new penem antibacterial agent. J Antimicrob Chemother. 1985 Jun;15 (Suppl 100):1–4. doi: 10.1093/jac/15.suppl_c.1. [DOI] [PubMed] [Google Scholar]
  4. Ganguly A. K., Girijavallabhan V. M., McCombie S., Pinto P., Rizi R., Jeffrey P. D., Lin S. Synthesis of Sch 29482--a novel penem antibiotic. J Antimicrob Chemother. 1982 Feb;9 (Suppl 100):1–5. doi: 10.1093/jac/9.suppl_c.1. [DOI] [PubMed] [Google Scholar]
  5. Kirkpatrick B., Ashby J., Wise R. Beta-lactams and imipenem. Lancet. 1986 Apr 5;1(8484):802–802. doi: 10.1016/s0140-6736(86)91811-8. [DOI] [PubMed] [Google Scholar]
  6. Nikaido H., Rosenberg E. Y., Foulds J. Porin channels in Escherichia coli: studies with beta-lactams in intact cells. J Bacteriol. 1983 Jan;153(1):232–240. doi: 10.1128/jb.153.1.232-240.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pearson R. D., Steigbigel R. T., Davis H. T., Chapman S. W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother. 1980 Nov;18(5):699–708. doi: 10.1128/aac.18.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Piddock L. J., Wise R. Properties of the penicillin-binding proteins of four species of the genus Bacteroides. Antimicrob Agents Chemother. 1986 May;29(5):825–832. doi: 10.1128/aac.29.5.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Reeves D. S., Wise R., Bywater M. J. A laboratory evaluation of a novel (beta-lactam antibiotic mecillinam. J Antimicrob Chemother. 1975 Sep;1(3):337–344. doi: 10.1093/jac/1.3.337. [DOI] [PubMed] [Google Scholar]
  10. Richmond M. H., Sykes R. B. The beta-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol. 1973;9:31–88. doi: 10.1016/s0065-2911(08)60376-8. [DOI] [PubMed] [Google Scholar]
  11. Wise R., Andrews J. M., Danks G. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics. Antimicrob Agents Chemother. 1983 Dec;24(6):909–914. doi: 10.1128/aac.24.6.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wise R., Andrews J. M., Patel N. N-formimidoyl-thienamycin a novel beta-lactam: an in-vitro comparison with other beta-lactam antibiotics. J Antimicrob Chemother. 1981 May;7(5):521–529. doi: 10.1093/jac/7.5.521. [DOI] [PubMed] [Google Scholar]
  13. Wise R., Gillett A. P., Cadge B., Durham S. R., Baker S. The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics. J Infect Dis. 1980 Jul;142(1):77–82. doi: 10.1093/infdis/142.1.77. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES